Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : How To Write Covered Calls - An Ongoing Real Case Study! -- Ignore unavailable to you. Want to Upgrade?

To: Johndee who wrote (8937)	11/5/1998 8:30:00 AM
From: Herm	Respond to of 14162

Johndee, INVX looks strong for the long run. I would not attempt to play INVX as a short by itself. I would CC IMVX and utilize W.I.N.S. tactics to milk it up and down. But, there are far better dogs out there for a short play. EXAMPLE OF CURRENT DOGS BSX - Accounting problems of overstating. CEOs have been terminated. The dust has not cleared on BSX and the shorts will be hammering it! Law suits are starting to roll in! It sure looks like more downside biz.yahoo.com. The stock may be way overpriced at this point even though the accounting indicates a discount. There may be a minimum $15 point drop in BSX in the near future. I would not be surprise to see BSX in the $20S price range before the end of 1998! BSX CHART askresearch.com BSX P/E VALUE BEFORE EXPECTED ADJUSTMENTS! NYSE: (BSX : $43 1/2) $8,712 million Market Cap at November 4, 1998 Ranks 706th in the Fortune 1,000 on Revenue & 425th on Profit. Employs 9,320. Trades at a 8% Discount PE Multiple of 25.0 X, vs. the 27.2 X average multiple at which the Medical Products SubIndustry is priced.